Veru Inc. (VERU): Net Income
-$22.73M
Year ended 2025-09-30
-$13.61M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$22.73M | n/m | 2025-12-17, From 2024-10-01 |
| 2024-09-30 | -$37.80M | n/m | 2025-12-17, From 2023-10-01 |
| 2023-09-30 | -$93.15M | n/m | 2024-12-16, From 2022-10-01 |
| 2022-09-30 | -$84.04M | n/m | 2024-04-01, From 2021-10-01 |
| 2021-09-30 | $7.39M | n/m | 2022-12-05, From 2020-10-01 |
| 2020-09-30 | -$18.97M | n/m | 2021-12-02, From 2019-10-01 |
| 2019-09-30 | -$12.02M | n/m | 2020-12-10, From 2018-10-01 |
| 2018-09-30 | -$23.94M | n/m | 2019-12-12, From 2017-10-01 |
| 2017-09-30 | -$6.61M | n/m | 2018-12-13, From 2016-10-01 |
| 2016-09-30 | $344.7K | -92.1% | 2018-01-02, From 2015-10-01 |
| 2015-09-30 | $4.35M | +78.6% | 2018-01-02, From 2014-10-01 |
| 2014-09-30 | $2.43M | -83.0% | 2016-12-12, From 2013-10-01 |
| 2013-09-30 | $14.34M | -6.3% | 2015-12-02, From 2012-10-01 |
| 2012-09-30 | $15.30M | +183.4% | 2014-12-02, From 2011-10-01 |
| 2011-09-30 | $5.40M | -19.9% | 2013-12-03, From 2010-10-01 |
| 2010-09-30 | $6.74M | +3.1% | 2012-12-04, From 2009-10-01 |
| 2009-09-30 | $6.54M | n/a | 2011-12-02, From 2008-10-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Veru Inc. (VERU) | 2025-09-30 | -$22.73M | n/m |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | -$6.13M | n/m |
| Talphera, Inc. (TLPH) | 2025-12-31 | -$14.29M | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$5.98M | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | -$26.48M | n/m |
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | -$34.50M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | -$3.19M | n/m |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | -$13.45M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$10.54M | n/m |
Compare VERU, SLGL, TLPH, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗